IN2012DN00899A - - Google Patents

Info

Publication number
IN2012DN00899A
IN2012DN00899A IN899DEN2012A IN2012DN00899A IN 2012DN00899 A IN2012DN00899 A IN 2012DN00899A IN 899DEN2012 A IN899DEN2012 A IN 899DEN2012A IN 2012DN00899 A IN2012DN00899 A IN 2012DN00899A
Authority
IN
India
Prior art keywords
culture system
cell culture
cell
continuous
less
Prior art date
Application number
Other languages
English (en)
Inventor
Grillberger Leopold
Reiter Manfred
Fleischanderl Daniel
Original Assignee
Baxter Healthcare Sa
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Healthcare Sa, Baxter Int filed Critical Baxter Healthcare Sa
Publication of IN2012DN00899A publication Critical patent/IN2012DN00899A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M3/00Tissue, human, animal or plant cell, or virus culture apparatus
    • C12M3/006Cell injection or fusion devices
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • C12N5/0056Xeno-free medium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489Metalloendopeptidases (3.4.24)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/98Xeno-free medium and culture conditions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/00051Methods of production or purification of viral material
    • C12N2710/00052Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24Metalloendopeptidases (3.4.24)
    • C12Y304/24087ADAMTS13 endopeptidase (3.4.24.87)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/52Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Sustainable Development (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
IN899DEN2012 2009-07-31 2010-08-02 IN2012DN00899A (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23031309P 2009-07-31 2009-07-31
PCT/EP2010/061191 WO2011012725A1 (en) 2009-07-31 2010-08-02 Method of producing a polypeptide or virus of interest in a continuous cell culture

Publications (1)

Publication Number Publication Date
IN2012DN00899A true IN2012DN00899A (enExample) 2015-04-03

Family

ID=42668436

Family Applications (1)

Application Number Title Priority Date Filing Date
IN899DEN2012 IN2012DN00899A (enExample) 2009-07-31 2010-08-02

Country Status (22)

Country Link
US (4) US8580554B2 (enExample)
EP (2) EP3480292A1 (enExample)
JP (2) JP5808742B2 (enExample)
KR (2) KR101752789B1 (enExample)
CN (1) CN102549142B (enExample)
AU (1) AU2010277490B2 (enExample)
BR (1) BR112012002137B8 (enExample)
CA (1) CA2769354A1 (enExample)
CO (1) CO6491119A2 (enExample)
DK (1) DK2459697T3 (enExample)
EA (1) EA022219B1 (enExample)
ES (1) ES2705206T3 (enExample)
HR (1) HRP20182165T1 (enExample)
IN (1) IN2012DN00899A (enExample)
MX (2) MX2012001274A (enExample)
NZ (1) NZ597742A (enExample)
PL (1) PL2459697T3 (enExample)
PT (1) PT2459697T (enExample)
SG (1) SG178176A1 (enExample)
SI (1) SI2459697T1 (enExample)
TR (1) TR201900213T4 (enExample)
WO (1) WO2011012725A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3626736T (pt) 2010-07-08 2025-08-11 Takeda Pharmaceuticals Co Método de produção de fvw recombinante de elevado peso molecular na cultura celular
SG191745A1 (en) * 2011-01-17 2013-08-30 Hoffmann La Roche Separation apparatus and use thereof
CA2835053C (en) 2011-05-13 2020-07-07 Octapharma Ag A method of increasing the productivity of eucaryotic cells in the production of recombinant fviii
KR101662412B1 (ko) * 2011-07-01 2016-10-04 암젠 인크 포유동물 세포 배양
CN203129697U (zh) 2013-02-05 2013-08-14 客贝利(厦门)休闲用品有限公司 一种帐篷架杆
CN104136605B (zh) 2011-11-24 2018-08-14 吉尼松公司 与工业制药应用相容的可放大的慢病毒载体生产系统
US9574167B2 (en) 2013-02-15 2017-02-21 Pharyx, Inc. Methods and apparatus for independent control of product and reactant concentrations
CN118388581A (zh) 2013-03-08 2024-07-26 建新公司 治疗性蛋白药物物质的整合连续制造
US9217168B2 (en) 2013-03-14 2015-12-22 Momenta Pharmaceuticals, Inc. Methods of cell culture
ES2842350T3 (es) 2013-03-19 2021-07-13 Cmc Biologics As Un procedimiento para la producción de un producto (por ejemplo, polipéptido) en un proceso de fermentación de cultivo celular continuo
CA2920934C (en) * 2013-08-30 2022-12-06 Glaxosmithkline Biologicals S.A. Large scale production of viruses in cell culture
US11390663B2 (en) 2013-10-11 2022-07-19 Regeneron Pharmaceuticals, Inc. Metabolically optimized cell culture
TWI671312B (zh) 2014-01-17 2019-09-11 美商健臻公司 無菌層析法及製法
TWI709569B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析樹脂及其用於製造方法的用途
KR20160146763A (ko) 2014-04-01 2016-12-21 어드밴텍 바이오사이언스 파마큐티카 엘티디에이 부형제로서 칼슘이 첨가되지 않은 factor viii의 안정화
JP2017509659A (ja) 2014-04-01 2017-04-06 アドヴァンテック・バイオサイエンス・ファルマスーティカ・リミターダ 低糖−低グリシンの安定な第viii因子製剤
CN106414719B (zh) * 2014-06-13 2020-02-14 杰特有限公司 生物反应器中重组von Willebrand因子的改进生产
KR20240173213A (ko) * 2016-01-26 2024-12-10 베링거 인겔하임 인터내셔날 게엠베하 연결된 관류 대 연속-유동식 교반-탱크 반응기 세포 배양 시스템
EP3443064A1 (en) * 2016-04-15 2019-02-20 Boehringer Ingelheim International GmbH Cell retention device and method
US20200063086A1 (en) * 2016-12-21 2020-02-27 Hoffmann-La Roche Inc. Growth control of eukaryotic cells
IL321253A (en) 2018-05-01 2025-08-01 Amgen Inc Antibodies with a modulated glycan profile
WO2019239780A1 (ja) * 2018-06-15 2019-12-19 富士フイルム株式会社 細胞培養方法、細胞培養装置、及び生産物の製造方法
BR112021003420A2 (pt) 2018-08-31 2021-05-18 Genzyme Corporation resina cromatográfica estéril e uso da mesma em processos de manufatura
CN113355297A (zh) * 2021-06-23 2021-09-07 吉林冠界生物技术有限公司 一种灌流式培养全悬浮mdck细胞生产重组禽流感病毒的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5019512A (en) 1989-03-17 1991-05-28 Baxter International Inc. Spin filter for removing substantially cell-free culture medium from suspension cell culture system
US5626734A (en) 1995-08-18 1997-05-06 University Technologies International, Inc. Filter for perfusion cultures of animal cells and the like
EP1325127B1 (en) 2000-10-02 2009-03-11 Novo Nordisk Health Care AG Method for the production of vitamin k-dependent proteins
AU2002342922A1 (en) * 2001-11-28 2003-06-10 Sandoz Ag Cell culture process
TWI384069B (zh) 2004-08-27 2013-02-01 Pfizer Ireland Pharmaceuticals 多胜肽之製法
AU2006257073B2 (en) 2005-06-17 2011-08-04 Children's Medical Center Corporation ADAMTS13-comprising compositions having thrombolytic activity
SI2522717T1 (sl) * 2006-01-04 2014-05-30 Baxter International Inc. Mediji celične kulture brez oligopeptidov
CA2709890A1 (en) * 2007-12-27 2009-07-09 Andre Giovagnoli Cell culture processes

Also Published As

Publication number Publication date
CA2769354A1 (en) 2011-02-03
US20190153400A1 (en) 2019-05-23
KR20120038531A (ko) 2012-04-23
WO2011012725A1 (en) 2011-02-03
BR112012002137A2 (pt) 2015-09-15
NZ597742A (en) 2014-02-28
JP5808742B2 (ja) 2015-11-10
JP6177260B2 (ja) 2017-08-09
US9650612B2 (en) 2017-05-16
TR201900213T4 (tr) 2019-02-21
HRP20182165T1 (hr) 2019-03-08
SG178176A1 (en) 2012-03-29
US10745672B2 (en) 2020-08-18
CN102549142B (zh) 2014-07-16
EP2459697B1 (en) 2018-10-17
US20140038264A1 (en) 2014-02-06
BR112012002137B8 (pt) 2020-05-12
SI2459697T1 (sl) 2019-03-29
PT2459697T (pt) 2019-01-21
US10221400B2 (en) 2019-03-05
EP2459697A1 (en) 2012-06-06
EA022219B1 (ru) 2015-11-30
MX353610B (es) 2018-01-18
EA201270213A1 (ru) 2012-06-29
PL2459697T3 (pl) 2019-04-30
AU2010277490A1 (en) 2012-02-09
EP3480292A1 (en) 2019-05-08
US20180051261A1 (en) 2018-02-22
KR101752789B1 (ko) 2017-06-30
CN102549142A (zh) 2012-07-04
US20110086411A1 (en) 2011-04-14
BR112012002137B1 (pt) 2020-04-14
CO6491119A2 (es) 2012-07-31
ES2705206T3 (es) 2019-03-22
KR101885046B1 (ko) 2018-08-02
US8580554B2 (en) 2013-11-12
DK2459697T3 (en) 2019-01-28
AU2010277490B2 (en) 2014-08-28
WO2011012725A8 (en) 2011-05-05
KR20170077286A (ko) 2017-07-05
JP2013500710A (ja) 2013-01-10
MX2012001274A (es) 2012-06-01
JP2015062436A (ja) 2015-04-09

Similar Documents

Publication Publication Date Title
MX353610B (es) Método para producir un polipéptido o virus de interés en un cultivo de células continuo.
JP2015521848A5 (enExample)
JP2016105737A5 (enExample)
NZ601424A (en) Method for the production of ad26 adenoviral vectors
AU2019268194A1 (en) Cell culture system
CA2830080C (en) Generation of nk cells and nk-cell progenitors
Konze et al. Cleavage of E-cadherin and β-catenin by calpain affects Wnt signaling and spheroid formation in suspension cultures of human pluripotent stem cells
NZ598677A (en) Production of proteins in glutamine-free cell culture media
NZ602958A (en) High level expression of recombinant toxin proteins
MX2012003654A (es) Metodos de produccion de glucoproteinas en cultivos de celulas de mamiferos usando glucocorticoides.
NZ593235A (en) Method for the production of recombinant adenovirus serotype 35
ATE488600T1 (de) Produktqualitätsverbesserung in säugerzellkulturverfahrenzur proteinproduktion
MX2009011805A (es) Mejora de las concentraciones de polipeptido del factor viii en cultivos celulares.
WO2001051616A3 (en) Techniques for growth and differentiation of human pluripotent stem cells
NZ586250A (en) Cell culture processes
WO2010089151A8 (en) Bioreactor for the cultivation of mammalian cells
MX353489B (es) Metodo para producir eritrocitos sin celulas alimentadoras.
NZ605403A (en) Method of producing recombinant adamts13 in cell culture
WO2008090770A1 (ja) L-アミノ酸を生産する微生物及びl-アミノ酸の製造法
MX2013005853A (es) Enzimas de fusion que tienen actividad de n-acetilglucosaminil transferasa.
AR084998A1 (es) Metodo de fermentacion de un sustrato gaseoso que comprende hidrogeno
EP4368699A3 (en) Methods of producing recombinant proteins
GB0602063D0 (en) Cell Culture
BR112013028006A2 (pt) método para aumentar a produtividade de células eucarióticas na produção do recombinante fviii
WO2011096750A3 (en) Method for preparing recombinant glycoproteins with high sialic acid content